)
Insmed (INSM) investor relations material
Insmed Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D., to serve until the 2029 Annual Meeting of Shareholders.
Advisory vote on the 2025 compensation of named executive officers.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026.
Other business may be considered as may properly come before the meeting or any adjournment or postponement.
Board of directors and corporate governance
Board recommends voting for all director nominees and all proposals presented.
Executive compensation and say-on-pay
Shareholders will cast an advisory vote on the 2025 compensation of named executive officers.
- Record 2025 revenues, major product approvals, and strong governance set the stage for continued growth.INSM
Proxy filing1 Apr 2026 - Late-stage pipeline and strong launches position for major growth and label expansions.INSM
Investor presentation25 Mar 2026 - ARIKAYCE improved symptoms and culture conversion, supporting label expansion in MAC lung disease.INSM
Study result23 Mar 2026 - Major clinical milestones and strong commercial execution drive growth across key therapeutic areas.INSM
Leerink Global Healthcare Conference 202610 Mar 2026 - Exceptional Q4 launch sets stage for sustained growth and major pipeline-driven expansion.INSM
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - 2026 revenues guided to at least $1.45B, driven by BRINSUPRI and ARIKAYCE growth.INSM
Q4 202519 Feb 2026 - Multiple late-stage assets and strong launches position for significant growth in 2026.INSM
Investor presentation19 Feb 2026 - Brensocatib's phase 3 success and ARIKAYCE's growth drive multi-billion-dollar expansion.INSM
51st Nasdaq London Investor Conference3 Feb 2026 - Q2 revenue up 17% to $90.3M; brensocatib advances toward NDA and commercial launch.INSM
Q2 20242 Feb 2026
Next Insmed earnings date
Next Insmed earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage